Ahmet Altıntaş
Research Subjects
Ahmet Altıntaş has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Sariyildirim
Department of Radiology, Osmaniye Training and Research Hospital, 80010 Osmaniye, Türkiye
2 shared publications - Binhan Aslan Akbulut
Department of Ophthalmology, SBÜ Adana City Training and Research Hospital, Adana, Turkey
2 shared publications - Emine Alyamaç Sukgen
Department of Ophthalmology, Sukgen Clinic, Adana, Turkey
2 shared publications - Mehmet Turan Ozer
Department of Internal Medicine, Osmaniye Training and Research Hospital, 80010 Osmaniye, Türkiye
2 shared publications - Tayyibe Saler
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ADANA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
2 shared publications - Ömer Tepe
Osmaniye Eğitim ve Araştırma Hastanesi
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 6 (4) , 52
Longitudinal Changes in Insulin Resistance Indices During SGLT2 Inhibitor Therapy in Type 2 Diabetes: A Prospective Observational Cohort Study
Background/Objectives: Glucose-lowering treatment can change insulin resistance indices without demonstrating improved insulin sensitivity. We described these changes during sodium–glucose cotransporter-2 (SGLT2) inhibitor therapy in routine care. Methods: In this prospective, uncontrolled observational cohort, 54 adults with type 2 diabetes were assessed at baseline, 3 and 6 months. Background medication was abstracted from hospital and prescription records. Exploratory baseline-to-6-month comparisons used Wilcoxon signed-rank tests with Benjamini–Hochberg adjustment across 15 analysed outcomes. Results: Median HOMA-IR decreased from 8.38 (IQR 3.47–13.26) to 3.14 (2.19–4.39), a 62.6% reduction in group medians (rank-biserial r = −0.79; adjusted p < 0.001); in the 41 participants without documented insulin use, the reduction was 50.9% (r = −0.76). Median triglyceride–glucose (TyG) index decreased from 9.45 to 9.04 (−4.3%; r = −0.63; adjusted p < 0.001). Change in HOMA-IR was not significantly correlated with change in HbA1c (ρ = −0.15; p = 0.27). Conclusions: Both indices decreased during follow-up, including in participants without documented insulin use, but these observations cannot establish a treatment effect or improved insulin sensitivity. TyG requires no insulin measurement but remains sensitive to glucose- and triglyceride-lowering therapies, including SGLT2 inhibitors. Controlled studies with direct measures of insulin sensitivity are needed.
- 6 November 2026
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 6 (4) , 52
Open AccessLongitudinal Changes in Insulin Resistance Indices During SGLT2 Inhibitor Therapy in Type 2 Diabetes: A Prospective Observational Cohort Study
Background/Objectives: Glucose-lowering treatment can change insulin resistance indices without demonstrating improved insulin sensitivity. We described these changes during sodium–glucose cotransporter-2 (SGLT2) inhibitor therapy in routine care. Methods: In this prospective, uncontrolled observational cohort, 54 adults with type 2 diabetes were assessed at baseline, 3 and 6 months. Background medication was abstracted from hospital and prescription records. Exploratory baseline-to-6-month comparisons used Wilcoxon signed-rank tests with Benjamini–Hochberg adjustment across 15 analysed outcomes. Results: Median HOMA-IR decreased from 8.38 (IQR 3.47–13.26) to 3.14 (2.19–4.39), a 62.6% reduction in group medians (rank-biserial r = −0.79; adjusted p < 0.001); in the 41 participants without documented insulin use, the reduction was 50.9% (r = −0.76). Median triglyceride–glucose (TyG) index decreased from 9.45 to 9.04 (−4.3%; r = −0.63; adjusted p < 0.001). Change in HOMA-IR was not significantly correlated with change in HbA1c (ρ = −0.15; p = 0.27). Conclusions: Both indices decreased during follow-up, including in participants without documented insulin use, but these observations cannot establish a treatment effect or improved insulin sensitivity. TyG requires no insulin measurement but remains sensitive to glucose- and triglyceride-lowering therapies, including SGLT2 inhibitors. Controlled studies with direct measures of insulin sensitivity are needed.
- 16 October 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 422
Retinal and choroidal microvascular changes in hemodialysis and peritoneal dialysis: a comparative OCT and OCTA study
Purpose This study aimed to evaluate retinal and choroidal structural and microvascular parameters using optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) in patients undergoing hemodialysis (HD) and peritoneal dialysis (PD). Furthermore, it aimed to compare short-term dialysis-associated ocular changes between the two dialysis modalities. Methods This prospective observational study encompassed 84 eyes from 46 patients undergoing either HD or PD. Ocular measurements were conducted at two time points according to the dialysis modality. Measurements for HD patients were taken before and after dialysis, whereas for PD patients, measurements were performed after dialysate drainage and following refilling. Comprehensive ophthalmologic assessments and OCT/OCTA imaging were performed. Statistical analyses were used to compare pre- and post-dialysis measurements and changes between the HD and PD groups. Results CMT significantly increased after dialysis, whereas subfoveal choroidal thickness significantly decreased. Systolic and diastolic blood pressures also decreased significantly. No significant changes were observed in OCTA-derived retinal microvascular parameters, including vessel density and FAZ parameters. A significant difference in ΔCMT was observed between the HD and PD groups (p = 0.002). Correlation analysis showed a moderate negative correlation between ΔCMT and the change in systolic blood pressure and a moderate positive correlation between ΔCMT and dialysis session duration. Conclusion Most OCTA-derived retinal microvascular parameters remained stable following dialysis, whereas small but statistically significant structural changes were observed in CMT and subfoveal choroidal thickness. The magnitude of short-term CMT change differed between HD and PD; however, the mechanism underlying this difference remains uncertain. OCT and OCTA may serve as useful non-invasive tools for evaluating ocular structural and microvascular changes in patients with ESRD undergoing dialysis.
- 16 October 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 422
Retinal and choroidal microvascular changes in hemodialysis and peritoneal dialysis: a comparative OCT and OCTA study
Purpose This study aimed to evaluate retinal and choroidal structural and microvascular parameters using optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) in patients undergoing hemodialysis (HD) and peritoneal dialysis (PD). Furthermore, it aimed to compare short-term dialysis-associated ocular changes between the two dialysis modalities. Methods This prospective observational study encompassed 84 eyes from 46 patients undergoing either HD or PD. Ocular measurements were conducted at two time points according to the dialysis modality. Measurements for HD patients were taken before and after dialysis, whereas for PD patients, measurements were performed after dialysate drainage and following refilling. Comprehensive ophthalmologic assessments and OCT/OCTA imaging were performed. Statistical analyses were used to compare pre- and post-dialysis measurements and changes between the HD and PD groups. Results CMT significantly increased after dialysis, whereas subfoveal choroidal thickness significantly decreased. Systolic and diastolic blood pressures also decreased significantly. No significant changes were observed in OCTA-derived retinal microvascular parameters, including vessel density and FAZ parameters. A significant difference in ΔCMT was observed between the HD and PD groups (p = 0.002). Correlation analysis showed a moderate negative correlation between ΔCMT and the change in systolic blood pressure and a moderate positive correlation between ΔCMT and dialysis session duration. Conclusion Most OCTA-derived retinal microvascular parameters remained stable following dialysis, whereas small but statistically significant structural changes were observed in CMT and subfoveal choroidal thickness. The magnitude of short-term CMT change differed between HD and PD; however, the mechanism underlying this difference remains uncertain. OCT and OCTA may serve as useful non-invasive tools for evaluating ocular structural and microvascular changes in patients with ESRD undergoing dialysis.
- Open Access
- 28 August 2026
- Published by MDPI AG in Preprints.org
Longitudinal Changes in Insulin Resistance Indices During SGLT2 Inhibitor Therapy in Type 2 Diabetes: A Prospective Single-Arm Cohort Study
Sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce cardiorenal events, but their association with insulin resistance in routine care is incompletely characterised, particularly where medication records cannot exclude exogenous insulin use. In this prospective, single-arm, single-centre cohort study, 54 adults with type 2 diabetes initiating an SGLT2 inhibitor were assessed at baseline, 3 and 6 months. Outcomes were HOMA-IR and the insulin-independent triglyceride–glucose (TyG) index within a family of 15 metabolic and laboratory variables, tested by Wilcoxon signed-rank test with Benjamini–Hochberg control and summarised as the rank-biserial correlation. Median HOMA-IR fell from 8.38 (IQR 3.47–13.26) to 3.14 (2.19–4.39), −62.6% (r = −0.79, adjusted p < 0.001), and the TyG index from 9.45 to 9.04 (−4.3%, r = −0.63, adjusted p < 0.001). Haemoglobin rose 5.0%, consistent with plasma-volume contraction. Change in HOMA-IR did not track change in HbA1c (ρ = −0.15, p = 0.27). An exploratory kidney-disease × time interaction was nominally significant for TyG (β = +0.31, p = 0.040) but not log-HOMA-IR (β = +0.39, p = 0.077). Because the design was single-arm and confounders unrecorded, these are associations observed during therapy, not treatment effects. The divergence between insulin-dependent and insulin-independent indices is relevant to endpoint selection in controlled studies.
- 28 August 2026
- Published by MDPI AG in Preprints.org
Open AccessLongitudinal Changes in Insulin Resistance Indices During SGLT2 Inhibitor Therapy in Type 2 Diabetes: A Prospective Single-Arm Cohort Study
Sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce cardiorenal events, but their association with insulin resistance in routine care is incompletely characterised, particularly where medication records cannot exclude exogenous insulin use. In this prospective, single-arm, single-centre cohort study, 54 adults with type 2 diabetes initiating an SGLT2 inhibitor were assessed at baseline, 3 and 6 months. Outcomes were HOMA-IR and the insulin-independent triglyceride–glucose (TyG) index within a family of 15 metabolic and laboratory variables, tested by Wilcoxon signed-rank test with Benjamini–Hochberg control and summarised as the rank-biserial correlation. Median HOMA-IR fell from 8.38 (IQR 3.47–13.26) to 3.14 (2.19–4.39), −62.6% (r = −0.79, adjusted p < 0.001), and the TyG index from 9.45 to 9.04 (−4.3%, r = −0.63, adjusted p < 0.001). Haemoglobin rose 5.0%, consistent with plasma-volume contraction. Change in HOMA-IR did not track change in HbA1c (ρ = −0.15, p = 0.27). An exploratory kidney-disease × time interaction was nominally significant for TyG (β = +0.31, p = 0.040) but not log-HOMA-IR (β = +0.39, p = 0.077). Because the design was single-arm and confounders unrecorded, these are associations observed during therapy, not treatment effects. The divergence between insulin-dependent and insulin-independent indices is relevant to endpoint selection in controlled studies.
- Open Access
- 6 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6106
Diabetic Retinopathy Grading and Concurrent Cardiorenal Biomarker Abnormalities in Type 2 Diabetes: Albuminuria and Elevated NT-proBNP—A Retrospective Cross-Sectional Study
Background: Diabetic retinopathy (DR) is the most prevalent microvascular complication of type 2 diabetes mellitus (T2DM) and a recognised marker of systemic vascular injury. Whether DR—graded independently by two experienced ophthalmologists as part of routine institutional care—is independently associated with concurrent nephropathy (urine albumin-to-creatinine ratio [UACR] ≥ 30 mg/g) and subclinical cardiac stress (N-terminal pro-B-type natriuretic peptide [NT-proBNP] ≥ 125 pg/mL) remains insufficiently examined. Methods: Retrospective cross-sectional study of 401 T2DM adults who underwent dilated fundus examination independently graded by two board-certified ophthalmologists (each ≥ 10 years’ experience in diabetic eye disease) using ETDRS-based classification. Inter-physician agreement was quantified by Cohen’s weighted kappa. The primary composite outcome was concurrent nephropathy and subclinical cardiac stress. Multivariable logistic regression adjusted for age, sex, HbA1c, diabetes duration, eGFR, hypertension, and pharmacological treatments. Results: The composite outcome was present in 120 (64.2%) DR-positive vs. 14 (6.5%) DR-negative patients (crude OR: 25.59 (13.78–47.51); p < 0.001; fully adjusted OR: 21.49 (11.02–41.81); p < 0.001). Inter-physician agreement was high (Cohen’s weighted κ = 0.88; 95% CI: 0.83–0.93). Nephropathy alone was found in 164 (87.7%) vs. 76 (35.5%) patients (OR: 12.95 (7.71–21.75); p < 0.001), and elevated NT-proBNP in 137 (73.3%) vs. 39 (18.2%) patients (OR: 12.29 (7.65–19.76); p < 0.001). A significant trend across DR severity grades was observed (p for trend < 0.001), although the gradient was not strictly monotonic. ROC AUC = 0.837 (95% CI: 0.784–0.860). Conclusions: Ophthalmologist-graded DR was independently associated with the concurrent presence of albuminuria and elevated NT-proBNP in T2DM. Because the design is cross-sectional, these findings describe association rather than prediction or causation. They generate the hypothesis that retinal grading may help flag patients in whom cardiorenal biomarker assessment is worth considering, but prospective validation is required before any screening application.
- 6 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6106
Open AccessDiabetic Retinopathy Grading and Concurrent Cardiorenal Biomarker Abnormalities in Type 2 Diabetes: Albuminuria and Elevated NT-proBNP—A Retrospective Cross-Sectional Study
Background: Diabetic retinopathy (DR) is the most prevalent microvascular complication of type 2 diabetes mellitus (T2DM) and a recognised marker of systemic vascular injury. Whether DR—graded independently by two experienced ophthalmologists as part of routine institutional care—is independently associated with concurrent nephropathy (urine albumin-to-creatinine ratio [UACR] ≥ 30 mg/g) and subclinical cardiac stress (N-terminal pro-B-type natriuretic peptide [NT-proBNP] ≥ 125 pg/mL) remains insufficiently examined. Methods: Retrospective cross-sectional study of 401 T2DM adults who underwent dilated fundus examination independently graded by two board-certified ophthalmologists (each ≥ 10 years’ experience in diabetic eye disease) using ETDRS-based classification. Inter-physician agreement was quantified by Cohen’s weighted kappa. The primary composite outcome was concurrent nephropathy and subclinical cardiac stress. Multivariable logistic regression adjusted for age, sex, HbA1c, diabetes duration, eGFR, hypertension, and pharmacological treatments. Results: The composite outcome was present in 120 (64.2%) DR-positive vs. 14 (6.5%) DR-negative patients (crude OR: 25.59 (13.78–47.51); p < 0.001; fully adjusted OR: 21.49 (11.02–41.81); p < 0.001). Inter-physician agreement was high (Cohen’s weighted κ = 0.88; 95% CI: 0.83–0.93). Nephropathy alone was found in 164 (87.7%) vs. 76 (35.5%) patients (OR: 12.95 (7.71–21.75); p < 0.001), and elevated NT-proBNP in 137 (73.3%) vs. 39 (18.2%) patients (OR: 12.29 (7.65–19.76); p < 0.001). A significant trend across DR severity grades was observed (p for trend < 0.001), although the gradient was not strictly monotonic. ROC AUC = 0.837 (95% CI: 0.784–0.860). Conclusions: Ophthalmologist-graded DR was independently associated with the concurrent presence of albuminuria and elevated NT-proBNP in T2DM. Because the design is cross-sectional, these findings describe association rather than prediction or causation. They generate the hypothesis that retinal grading may help flag patients in whom cardiorenal biomarker assessment is worth considering, but prospective validation is required before any screening application.
- 1 January 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (05) , 484-489
Short term ocular effects of dialysis type and the contribution of metabolic parameters
- 1 January 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (05) , 484-489
Short term ocular effects of dialysis type and the contribution of metabolic parameters